[1]古 红,王 静.血管性老年痴呆患者血清Sestrin 2,sFlt-1 水平与认知功能及预后的关系研究[J].现代检验医学杂志,2024,39(05):92-95+119.[doi:10.3969/j.issn.1671-7414.2024.05.017]
 GU Hong,WANG Jing.Study on the Relationship between Serum Sestrin 2, sFlt-1 Levels and Cognitive Function and Prognosis in Patients with Gerontic Vascular Dementia[J].Journal of Modern Laboratory Medicine,2024,39(05):92-95+119.[doi:10.3969/j.issn.1671-7414.2024.05.017]
点击复制

血管性老年痴呆患者血清Sestrin 2,sFlt-1 水平与认知功能及预后的关系研究()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第39卷
期数:
2024年05期
页码:
92-95+119
栏目:
论著
出版日期:
2024-09-15

文章信息/Info

Title:
Study on the Relationship between Serum Sestrin 2, sFlt-1 Levels and Cognitive Function and Prognosis in Patients with Gerontic Vascular Dementia
文章编号:
1671-7414(2024)05-092-05
作者:
古 红1王 静2
(1. 四川大学华西医院老年医学中心/ 干部医疗科,成都 610041;2. 成都市第二人民医院呼吸与危重医学科,成都 610021)
Author(s):
GU Hong1 WANG Jing2
(1. Geriatrics Center/Department of Cadre Medical, West China Hospital of Sichuan University, Chengdu 610041, China; 2. Department of Respiratory and Critical Care Medicine, Chengdu Second People’s Hospital, Chengdu 610021, China)
关键词:
Sestrin 2可溶性血管内皮生长因子受体-1血管性痴呆认知功能
分类号:
R749.16;R392.11
DOI:
10.3969/j.issn.1671-7414.2024.05.017
文献标志码:
A
摘要:
目的 探索血管性老年痴呆患者血清Sestrin 2,可溶性血管内皮生长因子受体-1(soluble vascular endothelialgrowth factor receptor-1,sFlt-1)水平与认知功能及预后的关系。方法 选取2021 年1 月~2023 年1 月在四川大学华西医院治疗的107 例血管性老年痴呆患者作为研究组,选择同期107 例健康体检者作为对照组。采用酶联免疫吸附法(ELISA)对血清Sestrin 2,sFlt-1 表达水平进行检测,比较不同简易精神状态量表(MMSE)评分患者血清Sestrin 2,sFlt-1 水平;Spearman 法分析血清Sestrin 2,sFlt-1 水平与MMSE 评分的相关性。比较不同预后功能障碍分级血管性老年痴呆患者血清Sestrin 2,sFlt-1 水平;受试者工作特征(ROC)曲线分析血清Sestrin 2,sFlt-1 检测对血管性老年痴呆患者预后功能障碍的预测价值。结果 研究组血清Sestrin2(15.57±1.56ng/ml),sFlt-1(35.68±1.56pg/ml)表达水平高于对照组(11.68±1.46ng/ml, 25.48±2.32pg/ml),差异具有统计学意义(t=18.833,21.363,均P<0.05)。随着MMSE 评分的升高,研究组患者血清Sestrin 2,sFlt-1 水平逐渐降低,差异具有统计学意义(F=134.682,29.284,均P<0.05)。研究组患者血清Sestrin 2,sFlt-1 水平与MMSE 评分呈负相关(r=-0.587,-0.554,均P<0.05);预后功能障碍分级Ⅲ级患者血清Sestrin 2,sFlt-1 水平高于Ⅰ ~ Ⅱ级患者(t=8.745,10.018,均P<0.05)。Sestrin 2 ,sFlt-1 联合预测的AUC 显著大于Sestrin 2,sFlt-1 单独预测的AUC(Z=2.348,2.059,P=0.019,0.040)。结论 血管性老年痴呆患者血清Sestrin 2,sFlt-1 水平升高,与患者的认知功能密切相关,二者联合具有一定的预后预测价值。
Abstract:
Objective To explore the relationship between serum Sestrin 2, soluble vascular endothelial growth factor receptor-1 (sFlt-1) levels and cognitive function and prognosis in patients with Gerontic Vascular Dementia. Methods A total of 107 patients with vascular dementia treated in West China Hospital of Sichuan University from January 2021 to January 2023 were selected as the study group, and 107 healthy individuals who underwent physical examinations during the same period were selected as the control group. Enzyme-linked immunosorbent assay (ELISA) method was used to detect the expression level of serum Sestrin 2 and sFlt-1. Different Minimum Mental State Examination (MMSE) scores were used to compare the serum Sestrin 2 and sFlt-1 levels of patients. Correlation between the serum Sestrin 2, sFlt-1 levels and the MMSE scores was analyzed by Spearman method. The differences in serum Sestrin 2 and sFlt-1 levels in patients with Gerontic Vascular Dementia with different prognostic dysfunction grades were compared, and the predictive value of serum Sestrin 2, sFlt-1 for prognostic dysfunction in patients with Gerontic Vascular Dementia was analyzed by the receiver operating characteristic (ROC) curve. Results Serum Sestrin 2 (15.57±1.56ng/ml) and sFlt-1(35.68±1.56pg/ml) expression levels were higher in the study group than those in the control group(11.68±1.46ng/ml, 25.48±2.32pg/ml), the differences were statistically significant (t=18.833, 21.363, all P<0.05). Serum Sestrin 2 and sFlt-1 levels were decreased in the patients in study group as the MMSE score increased, and the differences were statistically significant (F=134.682, 29.284, all P<0.05). Serum Sestrin 2 and sFlt-1 levels were negatively correlated with MMSE scores (r=-0.587, -0.554, all P<0.05). Serum Sestrin 2 and sFlt-1 levels of patients with prognostic dysfunction grading III were higher than those in patients with grades I-II (t=8.745, 10.018, all P<0.05). AUC predicted by combination of Sestrin2 and sFlt-1 was greater than AUC predicted by Sestrin 2 and sFlt-1 alone (Z=2.348, 2.059, P=0.019, 0.040). Conclusion Serum levels of Sestrin 2 and sFlt-1 are elevated in patients with vascular dementia, and they are closely related to cognitive function. The combination of the two may have certain prognostic value.

参考文献/References:

[1] WOLTERS F J, IKRAM M A. Epidemiology of vascular dementia[J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2019, 39(8): 1542-1549.
[2] IADECOLA C, DUERING M, HACHINSKI V, et al. Vascular cognitive impairment and dementia: JACC scientific expert panel[J]. Journal of the American College of Cardiology, 2019, 73(25): 3326-3344.
[3] WANG Peng, ZHAO Yipeng, LI Yixin, et al. Sestrin2 overexpression attenuates focal cerebral ischemic injury in rat by increasing Nrf2/HO-1 pathway-mediated angiogenesis[J]. Neuroscience, 2019, 410: 140-149.
[4] 蔡文灿, 刘熙君, 刘彦明, 等. 血清PLGF 和sFLT-1水平联合检测对急性ST 段抬高型心肌梗死患者PCI 术后MACE 复发的诊断价值研究[J]. 现代检验医学杂志, 2021, 36(2): 66-69. CAI Wencan, LIU Xijun, LIU Yanming, et al. Combined detection of serum PLGF and SFLT-1 levels in the diagnosis of MACE recurrence after PCI in patients with acute ST-segment elevation myocardial infarction[J]. Journal of Modern Laboratory Medicine, 2021, 36(2): 66-69.
[5] 贾建平, 陈生弟, 崔丽英, 等. 神经病学[M]. 7版.北京:人民卫生出版社, 2013:217-222. JIA Jianping, CHEN Shengdi, CUI Liying. Neurology[M]. 7th Ed. Beijing: People’s Medical Publishing House, 2013: 217-222.
[6] 亚拉盖, 图雅, 吉仁巴雅, 等. 血清NGF, BDNF,GFAP 水平与老年血管性痴呆严重程度的相关性分析[J]. 现代生物医学进展, 2019, 19(14): 2703-2706. YA Lagai, TU Ya, JI Renbaya, et al. Correlative analysis of serum NGF, BDNF and GFAP levels with the severity of senile vascular dementia[J]. Progress in Modern Biomedicine, 2019, 19(14): 2703-2706。
[7] 郝美美, 李晨曦. 血清Livin, IFN-γ 水平在血管性痴呆患者中的变化及其临床意义[J]. 卒中与神经疾病, 2018, 25(6): 668-671, 680. HAO Meimei, LI Chenxi. The changes and its clinical significance of serum Livin, IFN-γ in patients with vascular dementia[J]. Stroke and Nervous Diseases, 2018, 25(6): 668-671, 680.
[8] BIR S C, KHAN M W, JAVALKAR V, et al. Emerging concepts in vascular dementia: a review[J]. Journal of Stroke and Cerebrovascular Diseases, 2021, 30(8): 105864.
[9] HASE Y, JOBSON D, CHEONG J, et al. Hippocampal capillary pericytes in post-stroke and vascular dementias and Alzheimer’s disease and experimental chronic cerebral hypoperfusion[J]. Acta Neuropathologica Communications, 2024, 12(1): 29.
[10] 王红艳, 何海艳, 王玉川, 等. 血管性痴呆动物模型及病理机制研究进展[J]. 药物资讯, 2020, 9(2): 71-77. WANG Hongyan, HE Haiyan, WANG Yuchuan, et al. Research progress of vascular dementia in animal model and pathology[J]. Pharmacy Information, 2020, 9(2): 71-77.
[11] 陈静, 陈炜, 伍媛, 等. 中药有效成分多靶点调控治疗血管性痴呆的研究进展[J]. 广西医学, 2019,41(18): 2363-2365. CHEN Jing, CHEN Wei, WU Yuan, et al. Advances in multi-target mediation using active components of Chinese medicine for management of vascular dementia[J]. Guangxi Medical Journal, 2019, 41(18): 2363-2365.
[12] 杜双霞, 张晓红, 苑艳尊, 等. 血清氧化应激水平与血管性痴呆患者认知功能、神经损伤因子水平及预后的关系[J]. 山东医药, 2022, 62(5): 67-70. DU Shuangxia, ZHANG Xiaohong, YUAN Yanzun, et al. Relationship of serum oxidative stress level and cognitive function, nerve injury factors level and prognosis in patients with vascular dementia[J]. Shandong Medical Journal, 2022, 62(5): 67-70.
[13] 段新飞, 宋利宏, 胡科, 等. 血管性痴呆大鼠氧化应激、炎症反应与SIRT1 的相关性研究[J]. 精神医学杂志, 2020, 33(2): 122-125. DUAN Xinfei, SONG Lihong, HU Ke, et al. Correlation between oxidative stress, inflammatory response and SIRT1 in vascular dementia rats[J]. Journal of Psychiatry, 2020, 33(2): 122-125.
[14] ZHANG Jianbin, ZHANG Qianren, JIN Qian, et al. Sestrin2 maintains hepatic immune homeostasis and redox balance partially via inhibiting RIPK3-mediated necroptosis in metabolic dysfunction-associated steatohepatitis[J]. Molecular Metabolism, 2024, 80: 101865.
[15] CHE Xiaojing, CHAI Jiagui, FANG Yan, et al. Sestrin2 in hypoxia and hypoxia-related diseases[J]. Redox Report, 2021, 26(1): 111-116.
[16] 王迪, 啜红斐. 血清Sestrin2 水平与急性脑梗死患者氧化应激反应及早期神经功能恶化的关系[J]. 实用临床医药杂志, 2022, 26(6): 14-17, 22. WANG Di, CHUAI Hongfei. Correlations of serum Sestrin2 level with oxidative stress response and early deterioration of neurological function in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2022, 26(6): 14-17, 22.
[17] 雷晓鹏, 张泽平. 可溶性Fms 样酪氨酸激酶-1 预测急性颅脑损伤蛛网膜下腔出血后脑血管痉挛的研究[J]. 卒中与神经疾病, 2019, 26(4): 427-430, 434. LEI Xiaopeng, ZHANG Zeping. The study on the predictive effect of soluble Fms-like tyrosine kinase 1 on cerebral vasospasm after subarachnoid hemorrhage in acute craniocerebral injury[J]. Stroke and Nervous Diseases, 2019, 26(4): 427-430, 434.
[18] LIAO Li, ZHAO Xingtao, ZHOU Mengting, et al. sFlt-1: A double regulator in angiogenesis-related diseases[J]. Current Pharmaceutical Design, 2021, 27(40): 4160-4170.
[19] DRAKER N, TORRY D S, TORRY R J. Placenta growth factor and sFlt-1 as biomarkers in ischemic heart disease and heart failure: a review[J]. Biomarkers in Medicine, 2019, 13(9): 785-799.
[20] 吕霞, 周小燕, 焦黛妍. 血清sCAM-1, IGF-1 和sFlt-1 对自发性蛛网膜下腔出血后脑血管痉挛的病情与预后评估的价值[J]. 河北医药, 2022, 44(8):1194-1197. L? Xia, ZHOU Xiaoyan, JIAO Daiyan. The predictive and evaluation value of serum SCAM-1, IGF-1 and sFLT-1 levels in cerebral vasospasm after spontaneous subarachnoid hemorrhage[J]. Hebei Medical Journal, 2022, 44(8): 1194-1197.

备注/Memo

备注/Memo:
基金项目:四川省自然科学基金项目(2022NSFSC1463)。
作者简介:古红(1990-),女,本科,研究方向:老年呼吸系统、心血管系统、消化系统疾病等,E-mail:gzxpg5hd@163.com。
更新日期/Last Update: 2024-09-15